SFM
Sphera Funds Management Portfolio holdings
AUM
$382M
This Quarter Return
+4.59%
1 Year Return
+0.41%
3 Year Return
+99.29%
5 Year Return
+177.09%
10 Year Return
+575.73%
AUM
$624M
AUM Growth
+$624M
(+12%)
Cap. Flow
+$64.2M
Cap. Flow
% of AUM
10.29%
Top 10 Holdings %
Top 10 Hldgs %
33.26%
Holding
155
New
31
Increased
26
Reduced
30
Closed
22
Top Buys
| 1 |
Viatris
VTRS
|
$32M |
| 2 |
ALXN
Alexion Pharmaceuticals Inc
ALXN
|
$14.4M |
| 3 |
Amicus Therapeutics
FOLD
|
$9.79M |
| 4 |
Vertex Pharmaceuticals
VRTX
|
$9.74M |
| 5 |
Viking Therapeutics
VKTX
|
$7.53M |
Top Sells
| 1 |
Gilead Sciences
GILD
|
$18.6M |
| 2 |
Biogen
BIIB
|
$9.81M |
| 3 |
Ituran Location and Control
ITRN
|
$8.27M |
| 4 |
ORBK
Orbotech Ltd
ORBK
|
$6.62M |
| 5 |
Teva Pharmaceuticals
TEVA
|
$5.33M |
Sector Composition
| 1 | Healthcare | 80.48% |
| 2 | Technology | 4.94% |
| 3 | Communication Services | 3.07% |
| 4 | Financials | 1.38% |
| 5 | Consumer Discretionary | 1.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Cognizant
CTSH
$35.3B
| $3.91M | 0.46% | 55,086 +24,220 | +78% | +$1.72M |
|
52
Charter Communications
CHTR
$36.3B
| $3.91M | 0.46% | 11,629 -1,733 | -13% | -$582K |
|
|
IMMU
53
DELISTED
Immunomedics Inc
IMMU
| $3.72M | 0.44% | 230,000 -220,000 | -49% | -$3.56M |
|
|
AVEO
54
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $3.63M | 0.43% | 1,300,000 -100,000 | -7% | -$279K |
|
55
AnaptysBio
ANAB
$569M
| $3.53M | 0.41% | 35,000 -45,000 | -56% | -$4.53M |
|
56
Puma Biotechnology
PBYI
$254M
| $3.46M | 0.41% | +35,000 | New | +$3.46M |
|
57
X4 Pharmaceuticals
XFOR
$84.2M
| $3.44M | 0.4% | +269,268 | New | +$3.44M |
|
|
VBIV
58
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
| $3.42M | 0.4% | +800,000 | New | +$3.42M |
|
59
CytomX Therapeutics
CTMX
$336M
| $3.38M | 0.4% | 160,000 -50,000 | -24% | -$1.06M |
|
60
Abeona Therapeutics
ABEO
$350M
| $3.33M | 0.39% | +210,000 | New | +$3.33M |
|
|
ALNA
61
DELISTED
Allena Pharmaceuticals, Inc. Common Stock
ALNA
| $3.27M | 0.38% | +325,000 | New | +$3.27M |
|
|
IMGN
62
DELISTED
Immunogen Inc
IMGN
| $3.21M | 0.38% | +500,000 | New | +$3.21M |
|
|
MLNT
63
DELISTED
Melinta Therapeutics, Inc. Common Stock
MLNT
| $3.16M | 0.37% | +200,000 | New | +$3.16M |
|
64
Clearside Biomedical
CLSD
$28.9M
| $3.15M | 0.37% | 450,000 +150,000 | +50% | +$1.05M |
|
65
PDS Biotechnology
PDSB
$57.8M
| $3.13M | 0.37% | 333,737 | – | – |
|
66
BioMarin Pharmaceuticals
BMRN
$11.2B
| $3.12M | 0.37% | 35,000 -50,000 | -59% | -$4.46M |
|
|
CMTA
67
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
| $3.09M | 0.36% | 163,000 | – | – |
|
68
Lam Research
LRCX
$127B
| $3.05M | 0.36% | +16,580 | New | +$3.05M |
|
|
BOLD
69
DELISTED
Audentes Therapeutics, Inc
BOLD
| $2.97M | 0.35% | 95,000 | – | – |
|
70
Savara
SVRA
$567M
| $2.97M | 0.35% | 200,000 -326,315 | -62% | -$4.84M |
|
71
TherapeuticsMD
TXMD
$12.8M
| $2.9M | 0.34% | 479,980 +99,980 | +26% | +$604K |
|
72
Neurocrine Biosciences
NBIX
$13.8B
| $2.87M | 0.34% | 37,000 -50,000 | -57% | -$3.88M |
|
73
O'Reilly Automotive
ORLY
$88B
| $2.8M | 0.33% | 11,650 +9,950 | +585% | +$2.39M |
|
74
Expedia Group
EXPE
$26.6B
| $2.75M | 0.32% | +22,950 | New | +$2.75M |
|
75
Corbus Pharmaceuticals
CRBP
$115M
| $2.66M | 0.31% | +375,000 | New | +$2.66M |
|